US 8222422
Crystal of benzimidazole compound
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8222422 (Crystal of benzimidazole compound) held by Takeda Pharmaceutical Company Limited expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P29/00, A61P31/04